BioCentury | Jan 9, 2021
Finance

Targeted oncology is having a moment, again

...a hot target late in 2020 when Kura Oncology Inc....
BioCentury | Aug 25, 2020
Management Tracks

Former head of gRED Varney joining Erasca; plus AAM, City of Hope, Immunovant, Kura, Illumina and more

...his 17-year tenure at Johnson & Johnson (NYSE:JNJ) last year as VP of immunology scientific innovation.Kura Oncology Inc....
...was SVP, commercial North America at DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT). Robin Sawka Erasca Inc. City of Hope Immunovant Inc. Kura Oncology Inc. Illumina...
BioCentury | May 7, 2020
Finance

May 6 Quick Takes: Grail raises year’s largest venture round; plus fresh funds for Insmed, Kura, TG, BerGenBio, Limbix and Kineta

...to the rare disease company’s close of $24.86 on Monday. On Wednesday, precision cancer company Kura Oncology Inc....
...led by Schlaepfer Family Foundation. Targets AXL (UFO) - AXL receptor tyrosine kinase BioCentury Staff Kineta Inc. BerGenBio A/S Limbix Kura Oncology Inc. Insmed...
BioCentury | Feb 22, 2020
Management Tracks

Everest names new CEO; plus Merck, Gilead, Turning Point, Adaptimmune, AskBio and more

...as CMO, a newly created position. Gualberto co-founded and was CMO of precision oncology company Kura Oncology Inc....
BioCentury | Jan 25, 2020
Company News

Management tracks: Galapagos promotes Manto to CCO; plus Guardant, Horizon, Acceleron, Lilly, Krystal, Kura and more

...head of genetic diseases at the Genzyme unit of Sanofi (Euronext:SAN; NYSE:SNY). Precision oncology company Kura Oncology Inc....
...Laboratories L.P. BioCentury Staff Guardant Health Inc. Krystal Biotech Inc. Roivant Sciences GmbH Ergomed plc Galapagos N.V. Acceleron Pharma Inc. Eli Lilly and Co. Kura Oncology Inc....
BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...Healthcare Partners launched Phathom in May (see “Divergent Aftermarket Results for Phathom, Cabaletta IPOs” ). Kura Oncology Inc....
...operations at Array Biopharma, which Pfizer Inc. (NYSE:PFE) acquired in July. BioCentury Staff Aveo Pharmaceuticals Inc. Arrowhead Pharmaceuticals Inc. Kura Oncology Inc. Akcea...
BioCentury | Sep 3, 2019
Clinical News

Sept. 3 Clinical Quick Takes: Phase II failure for Aridis, plus Kura, Idorsia, Concert, PegBio

...Aridis fell $0.78 to $10.90 on Tuesday. Kura's bladder cancer therapy meets PFS endpoint Kura Oncology Inc....
...kinase Sandi Wong and Hongjiang Li, Staff Writers Aerucin (AR-105) CTP-543 PB-718 selatogrel (ACT-246475) tipifarnib (zarnestra, R115777) Aridis Pharmaceuticals Inc. Concert Pharmaceuticals Inc. Idorsia Ltd. Kura Oncology Inc. PegBio...
BioCentury | Aug 12, 2019
Company News

Management tracks: Bailey leaving GSK; plus HHS drug pricing adviser to depart and more

...index scheme (see "Newly Named Azar Adviser O'Brien Defends Pricing Index" ). Precision medicine company Kura Oncology Inc....
BioCentury | Aug 2, 2019
Company News

Management tracks: Third Rock-backed Thrive names new CEO; plus PhRMA, Adverum and more

...CFO of Regulus Therapeutics Inc. (NASDAQ:RGLS) and Deng was senior director, head of CMC at Kura Oncology...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...NASDAQ:RMTI) 6/18/19 $18.8 $190.2 $190.8 0% Calithera Biosciences Inc. (NASDAQ:CALA) 6/18/19 $57.5 $213.8 $208.5 -3% Kura Oncology Inc....
Items per page:
1 - 10 of 55
BioCentury | Jan 9, 2021
Finance

Targeted oncology is having a moment, again

...a hot target late in 2020 when Kura Oncology Inc....
BioCentury | Aug 25, 2020
Management Tracks

Former head of gRED Varney joining Erasca; plus AAM, City of Hope, Immunovant, Kura, Illumina and more

...his 17-year tenure at Johnson & Johnson (NYSE:JNJ) last year as VP of immunology scientific innovation.Kura Oncology Inc....
...was SVP, commercial North America at DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT). Robin Sawka Erasca Inc. City of Hope Immunovant Inc. Kura Oncology Inc. Illumina...
BioCentury | May 7, 2020
Finance

May 6 Quick Takes: Grail raises year’s largest venture round; plus fresh funds for Insmed, Kura, TG, BerGenBio, Limbix and Kineta

...to the rare disease company’s close of $24.86 on Monday. On Wednesday, precision cancer company Kura Oncology Inc....
...led by Schlaepfer Family Foundation. Targets AXL (UFO) - AXL receptor tyrosine kinase BioCentury Staff Kineta Inc. BerGenBio A/S Limbix Kura Oncology Inc. Insmed...
BioCentury | Feb 22, 2020
Management Tracks

Everest names new CEO; plus Merck, Gilead, Turning Point, Adaptimmune, AskBio and more

...as CMO, a newly created position. Gualberto co-founded and was CMO of precision oncology company Kura Oncology Inc....
BioCentury | Jan 25, 2020
Company News

Management tracks: Galapagos promotes Manto to CCO; plus Guardant, Horizon, Acceleron, Lilly, Krystal, Kura and more

...head of genetic diseases at the Genzyme unit of Sanofi (Euronext:SAN; NYSE:SNY). Precision oncology company Kura Oncology Inc....
...Laboratories L.P. BioCentury Staff Guardant Health Inc. Krystal Biotech Inc. Roivant Sciences GmbH Ergomed plc Galapagos N.V. Acceleron Pharma Inc. Eli Lilly and Co. Kura Oncology Inc....
BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...Healthcare Partners launched Phathom in May (see “Divergent Aftermarket Results for Phathom, Cabaletta IPOs” ). Kura Oncology Inc....
...operations at Array Biopharma, which Pfizer Inc. (NYSE:PFE) acquired in July. BioCentury Staff Aveo Pharmaceuticals Inc. Arrowhead Pharmaceuticals Inc. Kura Oncology Inc. Akcea...
BioCentury | Sep 3, 2019
Clinical News

Sept. 3 Clinical Quick Takes: Phase II failure for Aridis, plus Kura, Idorsia, Concert, PegBio

...Aridis fell $0.78 to $10.90 on Tuesday. Kura's bladder cancer therapy meets PFS endpoint Kura Oncology Inc....
...kinase Sandi Wong and Hongjiang Li, Staff Writers Aerucin (AR-105) CTP-543 PB-718 selatogrel (ACT-246475) tipifarnib (zarnestra, R115777) Aridis Pharmaceuticals Inc. Concert Pharmaceuticals Inc. Idorsia Ltd. Kura Oncology Inc. PegBio...
BioCentury | Aug 12, 2019
Company News

Management tracks: Bailey leaving GSK; plus HHS drug pricing adviser to depart and more

...index scheme (see "Newly Named Azar Adviser O'Brien Defends Pricing Index" ). Precision medicine company Kura Oncology Inc....
BioCentury | Aug 2, 2019
Company News

Management tracks: Third Rock-backed Thrive names new CEO; plus PhRMA, Adverum and more

...CFO of Regulus Therapeutics Inc. (NASDAQ:RGLS) and Deng was senior director, head of CMC at Kura Oncology...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...NASDAQ:RMTI) 6/18/19 $18.8 $190.2 $190.8 0% Calithera Biosciences Inc. (NASDAQ:CALA) 6/18/19 $57.5 $213.8 $208.5 -3% Kura Oncology Inc....
Items per page:
1 - 10 of 55